Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 3Phase NA 2Phase EARLY_PHASE1 1Phase 4 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 1

Conditions

Recombinant Human Thyroid Stimulating Hormone 1DTC - Differentiated Thyroid Cancer 1

Interventions

Exercise 419Blood Specimen Collection 319Standard of Care 299Surveys and Questionnaires 242Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 223Methods 221Radiotherapy 216Early Intervention, Educational 200Interviews as Topic 142Practice Guidelines as Topic 141Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 101Palliative Care 97Resistance Training 94Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Specimen Handling 73Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × OTHER × Thyrotropin Alfa × Clear all
NCT06431620 2024-05-28

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

Nanjing First Hospital, Nanjing Medical University

Phase NA Recruiting
15 enrolled
Head & Neck

Recombinant Human Thyroid Stimulating Hormone

NCT06405217 2024-05-08

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Nanjing First Hospital, Nanjing Medical University

Phase NA Recruiting
30 enrolled
EndocrineHead & Neck

DTC - Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡